Lori Corbin, breast cancer, cancer trial
The Benefit of Control
A positive attitude and an aggressive approach helped
46-year-old Lori Corbin through her journey with breast cancer. After a
self-breast exam in June of 2001 alerted her to a cancerous lump, Lori was
determined to deal with her diagnosis head-on and opted for a mastectomy
followed by reconstruction surgery. But it was the prospect of chemotherapy
that Lori found disheartening.
Side effects of chemotherapy can include anemia—a
decrease in red blood cells, which are necessary for the body to function.
Fatigue, a frequent side effect of chemotherapy-related anemia, can prevent
patients from participating in their everyday activities.
Lori’s oncology nurse, however, asked if she wanted to
participate in a clinical trial for a medicine called Epoetin alfa. After
hearing how the medicine could work to increase and keep her red blood cell
count up, Lori decided to try it.
“I would get my shot and it was amazing to me. I
was able the entire time to maintain my normal lifestyle. The medicine offered
a little control in something that you normally don't have control in.”